Table 1.
Structure | Drug | Method | In vitro/ in vivo activity | Reference |
---|---|---|---|---|
Baricitinib | knowledge graph | Significantly reduced viral load in human liver spheroids at 400 and 800 nM | [13–16] | |
Clemastine | Protein interaction map | pIC50 5.67 | [23] | |
Cloperastine | Protein interaction map | pIC50 5.27 | [23] | |
Amodiaquine | Ligand-based virtual screen | EC50 0.13 μM and 5.4 μM | [27] | |
Zuclopenthixol | Ligand-based virtual screen | 1.35 μM and 15 μM | [27] | |
Nebivolol | Ligand-based virtual screen | 2.72 μM and 2.8 μM | [27] | |
Dipyridamole | Docking in Mpro | IC50 0.53 μM, EC50~0.1 μM | [28] |